Skip to main content
The BMJ logoLink to The BMJ
letter
. 1996 Jan 6;312(7022):52. doi: 10.1136/bmj.312.7022.52

Quality of service provision for anticoagulation in atrial fibrillation. Difficulties of routine treatment are exaggerated.

T Marshall
PMCID: PMC2349682  PMID: 8555870

Full text

PDF

Page 52

52

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gottlieb L. K., Salem-Schatz S. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med. 1994 Sep 12;154(17):1945–1953. doi: 10.1001/archinte.154.17.1945. [DOI] [PubMed] [Google Scholar]
  2. Lancaster T. R., Singer D. E., Sheehan M. A., Oertel L. B., Maraventano S. W., Hughes R. A., Kistler J. P. The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med. 1991 Oct;151(10):1944–1949. [PubMed] [Google Scholar]
  3. Sudlow C. M., Rodgers H., Kenny R. A., Thomson R. G. Service provision and use of anticoagulants in atrial fibrillation. BMJ. 1995 Aug 26;311(7004):558–560. doi: 10.1136/bmj.311.7004.558. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES